Ketamine IV for the prevention of depression in the elderly: new data

Published Date: 13 Mar 2023

Intravenous (IV) ketamine is effective in adults resistant to depression. The response was similar to that seen in younger patients, two new studies show.

Read Full News

Latest News

Bundibugyo Ebola Update: Are New Defenses on the Horizon?

Global health agencies are accelerating vaccine and therapeutic research because the Bundibugyo Ebola outbreak highlights the absence of approved countermeasures.

Pediatric Ketamine Sedation Not Tied to Serious AEs

Children receiving ketamine sedation in the ED rarely have serious side effects, but risks are slightly higher in those who are older, those with respiratory infections, or those receiving opioids.

NICE Recommends Mepolizumab for Uncontrolled COPD

Mepolizumab is the second biologic approved for eosinophilic COPD this year, joining dupilumab in offering an alternative to triple therapy alone.

Diabetic Ketoacidosis Diagnosed Beyond Lab Criteria

Not all patients in the emergency department diagnosed with diabetic ketoacidosis meet laboratory criteria; a study shows that physicians rely on clinical signs and symptoms.

Older Age Tied to Higher CT Positivity in Abdominal Pain

Older adults visiting the emergency department for abdominal pain have higher risks for CT positivity and hospital admission than younger adults, despite less specific symptoms.

Texas Firearm Injuries: ED Admits Up, Costs Nearly Double

Firearm injuries continue to strain Texas emergency departments, with increasing hospitalizations and nearly doubled charges underscoring the growing burden on healthcare systems and communities.

Todays Updates

A Century of Schizophrenia: One Disorder or Many?

Researchers increasingly suggest that biological diversity within schizophrenia may limit efforts to identify a single defining biomarker.

Snus Linked to Gingival Damage, Raising Safety Questions

Research shows that snus and newer oral nicotine pouches are associated with localized soft tissue changes, prompting greater attention to their oral health effects.

Todays Updates

A Century of Schizophrenia: One Disorder or Many?

Researchers increasingly suggest that biological diversity within schizophrenia may limit efforts to identify a single defining biomarker.

Snus Linked to Gingival Damage, Raising Safety Questions

Research shows that snus and newer oral nicotine pouches are associated with localized soft tissue changes, prompting greater attention to their oral health effects.

Latest News

Global health agencies are accelerating vaccine and therapeutic research because the Bundibugyo Ebola outbreak highlights the absence of approved countermeasures.

Children receiving ketamine sedation in the ED rarely have serious side effects, but risks are slightly higher in those who are older, those with respiratory infections, or those receiving opioids.

Mepolizumab is the second biologic approved for eosinophilic COPD this year, joining dupilumab in offering an alternative to triple therapy alone.

Not all patients in the emergency department diagnosed with diabetic ketoacidosis meet laboratory criteria; a study shows that physicians rely on clinical signs and symptoms.

Older adults visiting the emergency department for abdominal pain have higher risks for CT positivity and hospital admission than younger adults, despite less specific symptoms.

Firearm injuries continue to strain Texas emergency departments, with increasing hospitalizations and nearly doubled charges underscoring the growing burden on healthcare systems and communities.

News All Time

AI Beats Physicians AVSs for Hospital Patients

AI over docs: AI-generated after-visit summaries are better than physician-generated ones, physician graders say. Next, patients will judge.

Can Rise of Direct Primary Care Ease Hospital Admissions?

Research has shown direct care may reduce emergency department visit and hospital use, but questions remain about equity.

US Kratom Use Surges 65-Fold in 13 Years

US Kratom use increased more than 65-fold from 2010 to 2023, with a lower incidence of adverse outcomes in states that banned the substance, new research shows.

Hydronephrosis on USG Predicts Stones but May Not Cut CT Use

Hydronephrosis identified on point-of-care ultrasound is linked to higher risks for stone disease and early urologic intervention in suspected renal colic but not with reduced CT use or ED stays.

Apnimed's Sleep Apnea Pill Meets Main Goal in Late-stage Study

Privately held biotech firm Apnimed said on Monday its experimental pill for a sleep disorder met the main ⁠goal in a late-stage trial, potentially offering a convenient...

Hidradenitis Suppurativa Tied to Higher Cardiovascular Risks

Individuals with HS show higher risks for cardiovascular outcomes, including hypertension, coronary or ischemic heart disease, venous thromboembolism, and myocardial infarction, in a meta-analysis.

African Public Health Agency Announces New Ebola Outbreak in Congo, 65 Suspected Deaths

Africa's top public health agency said on Friday that there was a confirmed Ebola outbreak in Democratic Republic of Congo's Ituri province, with 65 deaths out of 246...

Rapid Susceptibility Test Falls Short in Bacteremia

Rapid antimicrobial susceptibility testing of blood cultures is not superior to standard testing in patients with gram-negative bloodstream infections, according to the FAST trial.

Socioeconomic Gaps Tied to Concussion-Related ED Visits

Socioeconomic disparities determine where patients seek concussion care and patients' likelihood of receiving follow-up care, a study finds.

Balanced Fluid: No Renal Benefit Over Saline in Septic Shock

In children with septic shock, choosing balanced fluid over saline does not appear to change short-term kidney outcomes or survival.

Is Telemedicine Comparable to In-Person Neurology Care?

Virtual neurology care for new patients is comparable to in-person care, with similar 90-day follow-up rates, ED visits, and hospitalizations, a new study shows.

Regenxbio Shares Sink as Safety Concerns Overshadow Muscle Disorder Therapy Trial Win

Regenxbio said on Thursday that its experimental gene therapy for a muscle-wasting disorder met the main goal ⁠in a late-stage study, but its shares plunged 31% in morning...

US Drug Overdose Deaths Dropped for Third Straight Year in 2025, CDC Data Shows

Drug overdose deaths in the United States fell nearly ⁠14% in 2025, federal estimates showed on Wednesday, marking a third ⁠consecutive year of declines.

Common Practice of DOAC Switching After Stroke Challenged

A multicenter, registry-based cohort study showed no short-term benefit of the common practice of switching anticoagulants after a breakthrough ischemic stroke in patients with atrial fibrillation.

Resistant Gut Bacteria May Flag C difficile Infection Risk

Adults colonised with extended-spectrum beta-lactamase-producing bacteria in the intestinal tract may face higher odds of developing Clostridioides difficile infection.

High-Risk Mental Health Patients Left Unmonitored in A&E

A 3-year RCEM programme finds high-risk mental health patients in emergency departments are going unmonitored — though rates have improved significantly since 2023.

Recommended News For You

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Schizophrenia patients are motivated by music therapy.

Glioblastoma treatment breakthrough shows promise

Prostate cancer detection with PET CT and PET MRI is comparable.

What are the factors that cause oral mucositis to be severe after receiving radiation for head and neck cancer?

More Data from Population-Based Studies Show CRC Screening Lowers Cancer Death Risk.

Earlier Info on Financial Stress; Obesity and Second Cancers; Carcinogenic Condoms?

Recommended Articles For You

Mechanisms, Efficacy, and Survival Outcomes in AML, Squamous Cell Carcinoma, & Non-Hodgkin Lymphoma 

Case Study: Diagnostic and Therapeutic Challenges in Aplastic Anemia Mimicking Hypoplastic Myelodysplastic Syndrome 

Cancer Staging: Updates, Clinical Insights, and Educational Resources for Medical Professionals 

Precision to Personalization: Expanding Genetic Testing and Counseling in Oncology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Lung Cancer Screening Rates in Eligible Adults Remain Low, Uneven

2.

When Should Immunocompromised Individuals Receive a COVID Booster?

3.

The use of biomarkers in the treatment of breast lumps is at a crossroads.

4.

"Unusual" Cancers Following Pandemic; Triumph in TNBC; Clinical Trial Interrupted by Shortage.

5.

Efanesoctocog Alfa Prevented Bleeding in Kids With Severe Hemophilia A

1.

The Mysterious Pain of Scrotal Hematoma: A Guide to Diagnosis and Treatment

2.

The Different Types of Cysts and Why They Occur: Insights from a Dermatologist 

3.

Mechanistic Insights into Abraxane, Verzenio, and the Management of Chemotherapy-Induced Tachycardia

4.

The Importance of Having a Quick and Effective Heparin Antidote 

5.

Is AI The New Radiologist For Breast MRI?

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know

2.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III

3.

Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary

4.

Navigating the Complexities of Ph Negative ALL - Part VIII

5.

A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot